
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ulcerative colitis
Taku Kobayashi, Britta Siegmund, Catherine Le Berre, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 1029
Taku Kobayashi, Britta Siegmund, Catherine Le Berre, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 1029
Showing 1-25 of 1029 citing articles:
Stem cell-based therapy for human diseases
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 596
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 596
Hemicyanine‐Based Near‐Infrared Activatable Probes for Imaging and Diagnosis of Diseases
Ziling Zeng, Si Si Liew, Xin Wei, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 51, pp. 26454-26475
Closed Access | Times Cited: 245
Ziling Zeng, Si Si Liew, Xin Wei, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 51, pp. 26454-26475
Closed Access | Times Cited: 245
The influence of cytokines on the complex pathology of ulcerative colitis
Hiroshi Nakase, Noriko Sato, Naomi Mizuno, et al.
Autoimmunity Reviews (2021) Vol. 21, Iss. 3, pp. 103017-103017
Open Access | Times Cited: 223
Hiroshi Nakase, Noriko Sato, Naomi Mizuno, et al.
Autoimmunity Reviews (2021) Vol. 21, Iss. 3, pp. 103017-103017
Open Access | Times Cited: 223
Ulcerative colitis: an update
Jonathan Segal, Jean‐Frédéric LeBlanc, Ailsa Hart
Clinical Medicine (2021) Vol. 21, Iss. 2, pp. 135-139
Open Access | Times Cited: 206
Jonathan Segal, Jean‐Frédéric LeBlanc, Ailsa Hart
Clinical Medicine (2021) Vol. 21, Iss. 2, pp. 135-139
Open Access | Times Cited: 206
Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis
Yifan Qu, Xinyi Li, Fengying Xu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 198
Yifan Qu, Xinyi Li, Fengying Xu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 198
The Gut Microbiome and Inflammatory Bowel Diseases
Yue Shan, Mirae Lee, Eugene B. Chang
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 455-468
Open Access | Times Cited: 178
Yue Shan, Mirae Lee, Eugene B. Chang
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 455-468
Open Access | Times Cited: 178
The metabolic nature of inflammatory bowel diseases
Timon E. Adolph, Moritz Meyer, Julian Schwärzler, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 12, pp. 753-767
Closed Access | Times Cited: 163
Timon E. Adolph, Moritz Meyer, Julian Schwärzler, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 12, pp. 753-767
Closed Access | Times Cited: 163
Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
Jiaqin Liu, Jian Liu, Xiaoliang Tong, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 3255-3276
Open Access | Times Cited: 159
Jiaqin Liu, Jian Liu, Xiaoliang Tong, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 3255-3276
Open Access | Times Cited: 159
MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis
Dianbo Yao, Wanlin Dai, Ming Dong, et al.
EBioMedicine (2021) Vol. 74, pp. 103751-103751
Open Access | Times Cited: 141
Dianbo Yao, Wanlin Dai, Ming Dong, et al.
EBioMedicine (2021) Vol. 74, pp. 103751-103751
Open Access | Times Cited: 141
Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy
Cui Liu, Xiangji Yan, Yujie Zhang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 141
Cui Liu, Xiangji Yan, Yujie Zhang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 141
Dopamine, Immunity, and Disease
Breana Channer, Stephanie Matt, Emily Nickoloff-Bybel, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 62-158
Open Access | Times Cited: 140
Breana Channer, Stephanie Matt, Emily Nickoloff-Bybel, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 62-158
Open Access | Times Cited: 140
Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota
Siyuan Sun, Xiuxiu Xu, Ling Liang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 135
Siyuan Sun, Xiuxiu Xu, Ling Liang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 135
Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s
Yanyang Li, Xiaojing Wang, Yu‐Lin Su, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 6, pp. 1495-1507
Open Access | Times Cited: 122
Yanyang Li, Xiaojing Wang, Yu‐Lin Su, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 6, pp. 1495-1507
Open Access | Times Cited: 122
Excessive Apoptosis in Ulcerative Colitis: Crosstalk Between Apoptosis, ROS, ER Stress, and Intestinal Homeostasis
Yue Wan, Lei Yang, Shu Jiang, et al.
Inflammatory Bowel Diseases (2021) Vol. 28, Iss. 4, pp. 639-648
Closed Access | Times Cited: 120
Yue Wan, Lei Yang, Shu Jiang, et al.
Inflammatory Bowel Diseases (2021) Vol. 28, Iss. 4, pp. 639-648
Closed Access | Times Cited: 120
Mesenchymal Stem Cell‐Derived Extracellular Vesicles with High PD‐L1 Expression for Autoimmune Diseases Treatment
Fang Xu, Ziying Fei, Huaxing Dai, et al.
Advanced Materials (2021) Vol. 34, Iss. 1
Closed Access | Times Cited: 116
Fang Xu, Ziying Fei, Huaxing Dai, et al.
Advanced Materials (2021) Vol. 34, Iss. 1
Closed Access | Times Cited: 116
Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges
Shangyong Li, Hui Zhang, Kaiwei Chen, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1142-1149
Open Access | Times Cited: 116
Shangyong Li, Hui Zhang, Kaiwei Chen, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1142-1149
Open Access | Times Cited: 116
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 108
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 108
Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiome
Jiaqi Xu, Junchao Xu, Tongfei Shi, et al.
Advanced Materials (2022) Vol. 35, Iss. 3
Closed Access | Times Cited: 100
Jiaqi Xu, Junchao Xu, Tongfei Shi, et al.
Advanced Materials (2022) Vol. 35, Iss. 3
Closed Access | Times Cited: 100
Effect of Coptis chinensis franch and Magnolia officinalis on intestinal flora and intestinal barrier in a TNBS-induced ulcerative colitis rats model
Qian Xie, Hongyan Li, Rong Ma, et al.
Phytomedicine (2022) Vol. 97, pp. 153927-153927
Closed Access | Times Cited: 85
Qian Xie, Hongyan Li, Rong Ma, et al.
Phytomedicine (2022) Vol. 97, pp. 153927-153927
Closed Access | Times Cited: 85
Role of gut microbiota in infectious and inflammatory diseases
Miriãn Ferrão Maciel-Fiuza, Guilherme Cerutti Müller, Daniel Marques Stuart Campos, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 79
Miriãn Ferrão Maciel-Fiuza, Guilherme Cerutti Müller, Daniel Marques Stuart Campos, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 79
Inflammatory Bowel Disease
Lia Pierson Bruner, Anna Marie White, Siobhan Proksell
Primary Care Clinics in Office Practice (2023) Vol. 50, Iss. 3, pp. 411-427
Closed Access | Times Cited: 77
Lia Pierson Bruner, Anna Marie White, Siobhan Proksell
Primary Care Clinics in Office Practice (2023) Vol. 50, Iss. 3, pp. 411-427
Closed Access | Times Cited: 77
CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
Motahareh Arjomandnejad, Acadia L. Kopec, Allison M. Keeler
Biomedicines (2022) Vol. 10, Iss. 2, pp. 287-287
Open Access | Times Cited: 70
Motahareh Arjomandnejad, Acadia L. Kopec, Allison M. Keeler
Biomedicines (2022) Vol. 10, Iss. 2, pp. 287-287
Open Access | Times Cited: 70
Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice
Zhen‐Ping Zou, Yue Du, Ting-Ting Fang, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 2, pp. 199-212.e5
Open Access | Times Cited: 70
Zhen‐Ping Zou, Yue Du, Ting-Ting Fang, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 2, pp. 199-212.e5
Open Access | Times Cited: 70
Tuft Cells and Their Role in Intestinal Diseases
Sebastian Kjærgaard Hendel, Lauge Kellermann, Annika Hausmann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 69
Sebastian Kjærgaard Hendel, Lauge Kellermann, Annika Hausmann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 69
Mulberry Anthocyanins Ameliorate DSS-Induced Ulcerative Colitis by Improving Intestinal Barrier Function and Modulating Gut Microbiota
Jianling Mo, Jingdan Ni, Ming Zhang, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1674-1674
Open Access | Times Cited: 69
Jianling Mo, Jingdan Ni, Ming Zhang, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1674-1674
Open Access | Times Cited: 69